Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19

Int J Infect Dis. 2020 Oct:99:38-39. doi: 10.1016/j.ijid.2020.07.055. Epub 2020 Jul 29.

Authors

Eli S Rosenberg¹, David R Holtgrave², Tomoko Udo²

Affiliations

¹ University at Albany School of Public Health, State University of New York, Rensselaer, NY, United States. Electronic address: erosenberg2@albany.edu.
² University at Albany School of Public Health, State University of New York, Rensselaer, NY, United States.

No abstract available

Publication types

Letter
Comment

MeSH terms

Azithromycin
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections* / drug therapy
Humans
Hydroxychloroquine / therapeutic use
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Hydroxychloroquine
Azithromycin